Zhongchao Inc. (ZCMD)
| Market Cap | 4.05M -84.4% |
| Revenue (ttm) | 11.37M -28.3% |
| Net Income | -6.31M |
| EPS | -171.68 |
| Shares Out | 4.17M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 11,349,368 |
| Open | 0.8000 |
| Previous Close | 0.8053 |
| Day's Range | 0.7945 - 1.0800 |
| 52-Week Range | 0.7119 - 967.1990 |
| Beta | -0.03 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 21, 2026 |
About ZCMD
Zhongchao Inc. provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People’s Republic of China. It operates through two segments, MDMOOC services, and Sales of Patented Drugs. The company offers patient management services in the tumor and rare diseases field, internet healthcare services, and pharmaceutical services, and operates an online information platform. It also provides online and onsite health information services, healthcare education programs, and healthcare tr... [Read more]
Financial Performance
In 2025, Zhongchao's revenue was $11.37 million, a decrease of -28.30% compared to the previous year's $15.86 million. Losses were -$6.31 million, 881.0% more than in 2024.
Financial StatementsNews
Zhongchao prices 4.55M Class A shares at $1.10 in registered direct offering
Zhongchao (ZCMD) announced that it has entered into a definitive agreement with certain investors for the purchase and sale of an aggregate of 4,545,455 of the company’s Class A Ordinary…
Zhongchao Inc. Announces $5.0 Million Registered Direct Offering
SHANGHAI, July 23, 2026 /PRNewswire/ -- Zhongchao Inc ("Zhongchao" or the "Company") (NASDAQ: ZCMD), today announced that it has entered into a definitive agreement with certain investors for the purc...
Zhongchao Inc trading halted, news pending
19:50 EDT Zhongchao (ZCMD) Inc trading halted, news pending
Zhongchao implements 1-for-3 share consolidation
Zhongchao (ZCMD) will effectuate a 1-for-3 share consolidation of the company’s ordinary shares of 24.8c par value each. Beginning with the opening of trading on June 29, the company’s Class…
Zhongchao Inc. Announces 1-for-3 Share Consolidation
SHANGHAI, June 25, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other ...
Zhongchao Inc trading halted, news pending
19:50 EDT Zhongchao (ZCMD) Inc trading halted, news pending
Zhongchao implements 1-for-31 share consolidation
Zhongchao (ZCMD) will effectuate a 1-for-31 share consolidation of the company’s ordinary shares of 0.008 par value each. Beginning with the opening of trading on June 8, the company’s Class…
Zhongchao Inc. Announces 1-for-31 Share Consolidation
SHANGHAI, June 4, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other m...
Zhongchao 9.26M share Spot Secondary priced at $0.54
Univest Securities acted as sole book running manager for the offering.
Zhongchao Inc. Announces Pricing of $5 Million Best Efforts Public Offering
SHANGHAI, May 29, 2026 /PRNewswire/ -- Zhongchao Inc. ("Zhongchao" or the "Company") (NASDAQ: ZCMD), a platform-based internet technology company offering services for patients with cancer and other m...
Zhongchao files to sell 5.56M units
Zhongchao (ZCMD) is offering on a best-efforts basis up to 5.56M units, consisting of one Class A ordinary share, or, in lieu thereof, a pre-funded warrant; and one warrant to…
Zhongchao Inc trading halted, news pending
19:50 EST Zhongchao (ZCMD) Inc trading halted, news pending
Zhongchao announces 1-for-8 share consolidation
Zhongchao (ZCMD) will effectuate a 1-for-8 share consolidation of the company’s ordinary shares of $0.001 par value each. Beginning with the opening of trading on March 2, the company’s Class…
Zhongchao Inc. Announces 1-for-8 Share Consolidation
SHANGHAI, Feb. 26, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other ...
Zhongchao files $300M mixed securities shelf
16:07 EDT Zhongchao files $300M mixed securities shelf
Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications
SHANGHAI , March 12, 2024 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and othe...
Zhongchao Inc trading halted, news pending
19:50 EST Zhongchao Inc trading halted, news pending
Zhongchao announces 1-for-10 share consolidation
Zhongchao approved a 1-for-10 share consolidation of the company’s ordinary shares of $0.0001 par value each. Beginning with the opening of trading on February 29, the company’s Class A ordinary…
Zhongchao Inc. Announces 1-for-10 Share Consolidation
SHANGHAI , Feb. 27, 2024 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other...
Zhongchao collaborates with health foundation to support cancer treatment
Zhongchao announced that Shanghai Zhongxin Medical Technology, of which Zhongchao consolidates the operations and financial results through a series of contractual arrangements, has renewed its servic...
Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments
SHANGHAI , Dec. 11, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other...
Zhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness Day
SHANGHAI , Oct. 23, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other...
Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients
SHANGHAI , Sept. 25, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and othe...
Zhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease Management
SHANGHAI , Aug. 24, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other...
Zhongchao Inc. Partners with Ximalaya to Launch the First Audio Course Series for Cancer Education
SHANGHAI , July 11, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other...